Pacific Edge slashes team on US 'uncertainty'

Pacific Edge slashes team on US 'uncertainty'
(Image: PEB)
Brent Melville
Pacific Edge has halved its sales team after uncertainty over its future in its core US market, with a pending decision on whether medicare contractor Novitas will cover US testing.  The cancer diagnostic company, dual listed on the New Zealand and Australian stock exchanges, slashed its commercial team from 34 to 17 as it restructured its operations after a 17.78% drop in test volumes for its Cxbladder product in its core US market for the December quarter.The Dunedin firm said it had processed 7,172 tests during the final three months of...

More Markets

Key says insider trading claim without merit
Markets

Key says insider trading claim without merit

US claimants target the company's directors over share prices and trading.

Positive Gentrack result gives sharemarket a boost
Markets Market close

Positive Gentrack result gives sharemarket a boost

The S&P/NZX 50 Index closed at 11,720.8, up 35.92 points or 0.31%.

Comvita opens books to bidder, cuts costs
Markets

Comvita opens books to bidder, cuts costs

The honey firm is finding a further $10m in costs to cut as it also cuts back guidance.

The Warehouse forced back to basics
Markets

Rebecca Stevenson: The Warehouse forced back to basics

While its rivals were fighting for customers, The Warehouse obsessed about itself.